Phosphoglycerate mutase (PGAM) deficiency causes a rare metabolic myopathy characterized by exercise-related myalgia and myoglobinuria. This disorder was described in 13 patients and five different mutations in the PGAM-M gene were identified. We report on a new patient with an unusual clinical presentation. As a youth, he participated in different sports without complaining of muscular symptoms, but at 44 years of age, after a brief, intense effort, he experienced lightheadedness without fainting. Serum CK was elevated and the ischemic exercise test showed a pathological lactate response. Muscle biopsy showed only mild abnormalities, but biochemical study revealed a defect of PGAM and genetic analysis showed two different mutations in t...
International audienceGlycogen storage disease type XV (GSD XV) is a recently described muscle glyco...
International audienceWe recently identified polyglucosan body myopathy-2, a pure skeletal myopathic...
We consider recent developments in disorders affecting three areas of metabolism: glycogen, fatty ac...
We report two patients in whom phosphoglycerate mutase (PGAM) deficiency was associated with the tri...
INTRODUCTION: Phosphoglycerate mutase deficiency (PGAM) is a rare metabolic myopathy that results in...
Muscle phosphoglycerate mutase (PGAM) deficiency has been so far identified in only six patients, fi...
Biochemical analysis of muscle in a 37-year-old man with exercise intolerance, myalgia, recurrent my...
McArdle's disease is an autosomal recessive glycogenosis due to mutation in the myophosphorylase gen...
To evaluate the proportion of cases of myoglobinuria that can be ascribed to specific metabolic defe...
Mutations in the guanosine diphosphate mannose (GDP-mannose) pyrophosphorylase B (GMPPB) gene encodi...
Pathogenic variants in the PGAM2 gene are associated with glycogen storage disease type X (GSDX) and...
Objective: It is unclear to what extent muscle phosphorylase b kinase (PHK) deficiency is associated...
Glycogenosis VII (GSD VII) is a rare autosomal recessive glycogen storage disorder caused by mutatio...
McArdle disease or Glycogen Storage Disease type V (GSD V; myophosphorylase deficiency; MIM 232600) ...
Mutations in PGM1 (phosphoglucomutase 1) cause Glycogen Storage Disease type XIV, which is also a co...
International audienceGlycogen storage disease type XV (GSD XV) is a recently described muscle glyco...
International audienceWe recently identified polyglucosan body myopathy-2, a pure skeletal myopathic...
We consider recent developments in disorders affecting three areas of metabolism: glycogen, fatty ac...
We report two patients in whom phosphoglycerate mutase (PGAM) deficiency was associated with the tri...
INTRODUCTION: Phosphoglycerate mutase deficiency (PGAM) is a rare metabolic myopathy that results in...
Muscle phosphoglycerate mutase (PGAM) deficiency has been so far identified in only six patients, fi...
Biochemical analysis of muscle in a 37-year-old man with exercise intolerance, myalgia, recurrent my...
McArdle's disease is an autosomal recessive glycogenosis due to mutation in the myophosphorylase gen...
To evaluate the proportion of cases of myoglobinuria that can be ascribed to specific metabolic defe...
Mutations in the guanosine diphosphate mannose (GDP-mannose) pyrophosphorylase B (GMPPB) gene encodi...
Pathogenic variants in the PGAM2 gene are associated with glycogen storage disease type X (GSDX) and...
Objective: It is unclear to what extent muscle phosphorylase b kinase (PHK) deficiency is associated...
Glycogenosis VII (GSD VII) is a rare autosomal recessive glycogen storage disorder caused by mutatio...
McArdle disease or Glycogen Storage Disease type V (GSD V; myophosphorylase deficiency; MIM 232600) ...
Mutations in PGM1 (phosphoglucomutase 1) cause Glycogen Storage Disease type XIV, which is also a co...
International audienceGlycogen storage disease type XV (GSD XV) is a recently described muscle glyco...
International audienceWe recently identified polyglucosan body myopathy-2, a pure skeletal myopathic...
We consider recent developments in disorders affecting three areas of metabolism: glycogen, fatty ac...